Even tho i cannot 100% say for sure that BPC-157 was the reason that both treated areas are now feeling better after the therapy I can with certainty say that i did not experience any systemic healing effects on untreated areas that are now exhibiting similar symptoms
Pagnamenta AT, Wing K, Sadighi Akha E, Knight SJL, Blte S, Schmtzer G, Duketis E, Poustka F, Klauck SM, Poustka A, Ragoussis J, Bailey AJ, Monaco AP, (IMGSAC) and the IMGS of AC (2009) A 15q13.3 microdeletion segregating with autism
A metabolism-focused framework can help regulators and investigators by making the therapeutic claim testable: the product should have a defined metabolic target, a reproducible potency assay, a biologically plausible delivery window and biomarkers showing that the target changed in treated patients
Our physicians monitor your response carefully and adjust dosing if needed to maintain optimal tolerability while maximizing therapeutic benefits
doi:10.1007/s12178-025-09971-w Villarreal-Espinosa JB, Berreta RS, Pallone L, et al